Aquestive Therapeutics, Inc. AQST Costs associated with public offering-ATM in Accounts Payable
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s costs associated with public offering-atm in accounts payable.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s costs associated with public offering-atm in accounts payable?
- Aquestive Therapeutics, Inc. (AQST) reported costs associated with public offering-atm in accounts payable of $0 in Q1 2026.